SCHEMBL10071036

SCHEMBL10071036

COC1Oc2cc3c(O)cc4c(c3cc2O1)-c1ccccc1C41CC2CCC1C2

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 6/20 0.39
ALOX5 P09917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041189 0.85 ALOX5AP (0.40) ALOX5APALOX5
SCHEMBL13452532 0.80 ALOX5AP (0.49) ALOX5APALOX5
SCHEMBL15247944 0.80 ALOX5AP (0.43) ALOX5APALOX5
SCHEMBL10069949 0.80
SCHEMBL12634354 0.78 ALOX5AP (0.38) ALOX5APALOX5
SCHEMBL16300297 0.78 ALOX5AP (0.38) ALOX5APALOX5
SCHEMBL13556802 0.78 ALOX5AP (0.36) ALOX5AP
SCHEMBL4568713 0.78 ALOX5AP (0.38) ALOX5APALOX5
SCHEMBL13868717 0.77 ALOX5AP (0.37) ALOX5APALOX5
SCHEMBL10041156 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120161089-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161089-A1 CHROMENE COMPOUND CYP8B1, HSD3B2, CYP17A1 ALOX5AP 3825/4885ALOX5 3771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.